<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ngcobo A</submitter><funding>National Research Foundation</funding><pagination>338</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10968400</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(3)</volume><pubmed_abstract>Purple sweet potatoes (&lt;i>Ipomoea batatas&lt;/i> (L.) genotype) in Southern Africa have a phytonutritional composition and antioxidant properties that can increase incomes and improve nutrition. This study compared the phytonutrient composition and antioxidant properties of four purple-colour sweet potato genotypes (local Purple-purple, '2019-1-1', and USA genotypes, '08-21P' and '16-283P'). These purple sweet potato genotypes were characterised by UPLC/QTOF/MS and 16 phenolic compounds were identified. Purple-purple (very dark purple) showed the highest concentration of cyanidins and peonidin derivatives. Chlorogenic acid derivatives were highest in the genotype '16-283P'. 'Puple-purple' and '16-283P' displayed the strongest antioxidant power and scavenging activities. Diaffeoylquinic acid isomer 1 was identified as the marker candidate for distinguishing the four purple sweet potato genotypes. Southern Africa's highest-protein sweet potato genotypes are Purple-purple (28.81 g/100 g) and '08-21 P' (24.31 g/100 g). A 13.65 g portion of '2019-1-1' would meet the Recommended Dietary Allowance (RDA) for iron for men, while 25.59 g would meet the RDA for children, and 30.72 g would meet the RDA for women. The sweet potato root of genotype '2019-1-1' provides 31.43 g of Zn per day for children and 22.86 g for adults. The roots of local cultivar Purple-purple can be used as functional food ingredients.</pubmed_abstract><journal>Antioxidants (Basel, Switzerland)</journal><pubmed_title>Phytonutritional Composition and Antioxidant Properties of Southern African, Purple-Fleshed Sweet Potato (&lt;i>Ipomoea batatas&lt;/i> (L.) Lam.) Storage Roots.</pubmed_title><pmcid>PMC10968400</pmcid><funding_grant_id>98352</funding_grant_id><pubmed_authors>Seke F</pubmed_authors><pubmed_authors>Ngcobo A</pubmed_authors><pubmed_authors>Mianda SM</pubmed_authors><pubmed_authors>Sunette LM</pubmed_authors><pubmed_authors>Sivakumar D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Phytonutritional Composition and Antioxidant Properties of Southern African, Purple-Fleshed Sweet Potato (&lt;i>Ipomoea batatas&lt;/i> (L.) Lam.) Storage Roots.</name><description>Purple sweet potatoes (&lt;i>Ipomoea batatas&lt;/i> (L.) genotype) in Southern Africa have a phytonutritional composition and antioxidant properties that can increase incomes and improve nutrition. This study compared the phytonutrient composition and antioxidant properties of four purple-colour sweet potato genotypes (local Purple-purple, '2019-1-1', and USA genotypes, '08-21P' and '16-283P'). These purple sweet potato genotypes were characterised by UPLC/QTOF/MS and 16 phenolic compounds were identified. Purple-purple (very dark purple) showed the highest concentration of cyanidins and peonidin derivatives. Chlorogenic acid derivatives were highest in the genotype '16-283P'. 'Puple-purple' and '16-283P' displayed the strongest antioxidant power and scavenging activities. Diaffeoylquinic acid isomer 1 was identified as the marker candidate for distinguishing the four purple sweet potato genotypes. Southern Africa's highest-protein sweet potato genotypes are Purple-purple (28.81 g/100 g) and '08-21 P' (24.31 g/100 g). A 13.65 g portion of '2019-1-1' would meet the Recommended Dietary Allowance (RDA) for iron for men, while 25.59 g would meet the RDA for children, and 30.72 g would meet the RDA for women. The sweet potato root of genotype '2019-1-1' provides 31.43 g of Zn per day for children and 22.86 g for adults. The roots of local cultivar Purple-purple can be used as functional food ingredients.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-04T23:53:12.547Z</modification><creation>2025-04-04T23:53:12.547Z</creation></dates><accession>S-EPMC10968400</accession><cross_references><pubmed>38539871</pubmed><doi>10.3390/antiox13030338</doi></cross_references></HashMap>